Latest Breaking News On - Bellus health inc - Page 2 : vimarsana.com

BELLUS Health (TSE:BLU) Shares Down 0 1%

BELLUS Health Inc. (TSE:BLU – Get Free Report)’s share price was down 0.1% on Monday . The stock traded as low as C$19.24 and last traded at C$19.48. Approximately 28,666 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 59,471 shares. The stock had previously closed at C$19.50. […]

Bellus health incHealth dailyHealth trading downHealth company profileHealth incGet free reportTrading downBellus healthTse blu

Canadian Market Modestly Lower As Technology, Materials Shares Post Losses

The Canadian market is down in negative territory Thursday afternoon, weighed down by losses in technology, materials and healthcare sections..

United statesOceanagold corpTilray incMining corpBellus health incText corpGold corpShopify incPan american silver corpConverge technology solutionsCelestica incInformation technology capped indexTecsys incSienna senior living incLightspeed commerceOpen text corp

Canadian Market Modestly Lower As Technology, Materials Shares Post Losses

The Canadian market is down in negative territory Thursday afternoon, weighed down by losses in technology, materials and healthcare sections..

United statesGold corpCelestica incText corpTilray incShopify incInformation technology capped indexBellus health incPan american silver corpSienna senior living incTecsys incOceanagold corpMining corpConverge technology solutionsLightspeed commerceOpen text corp

BELLUS Health (TSE:BLU) Share Price Crosses Below 50 Day Moving Average of $19 53

BELLUS Health (TSE:BLU) Share Price Crosses Below 50 Day Moving Average of $19 53
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Health price performanceHealth dailyBellus health incHealth incGet free reportLifesci capital

GSK completes acquisition of chronic cough-focused Bellus Health

(Alliance News) - GSK PLC on Wednesday said it completed its acquisition of Quebec-based late-stage biopharmaceutical firm Bellus Health Inc for a total equity value of USD2.0 billion. GSK, the Brentford, London-based pharmaceutical company, back in Apr.

United kingdomCity ofLuke mielsTom budszusAlliance news ltdBellus health incAlliance newsCommercial officer luke mielsAll rights